Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticlePRACTICE STANDARDS
Open Access

SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET

Thomas A. Hope, Jeremie Calais, Ajit H. Goenka, Uwe Haberkorn, Mark Konijnenberg, Jonathan McConathy, Daniela E. Oprea-Lager, Laura Trimnal, Elcin Zan, Ken Herrmann and Christophe M. Deroose
Journal of Nuclear Medicine January 2025, 66 (1) 26-33; DOI: https://doi.org/10.2967/jnumed.124.269002
Thomas A. Hope
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
2UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California;
3Department of Radiology, San Francisco VA Medical Center, San Francisco, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
4Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California;
5Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajit H. Goenka
6Department of Radiology, Mayo Clinic, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Haberkorn
7Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Konijnenberg
8Radiology and Nuclear Medicine Department, Erasmus MC, Rotterdam, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan McConathy
9Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela E. Oprea-Lager
10Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Trimnal
3Department of Radiology, San Francisco VA Medical Center, San Francisco, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elcin Zan
11Department of Radiology, Cleveland Clinic, Cleveland, Ohio;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
12Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
13German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe M. Deroose
14Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium; and
15Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 66 no. 1 26-33
DOI 
https://doi.org/10.2967/jnumed.124.269002
PubMed 
39572227

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 16, 2024
  • Accepted for publication October 16, 2024
  • Published online January 3, 2025.

Article Versions

  • previous version (November 21, 2024 - 06:07).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2025 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions.

Author Information

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 177Lu-LNC1004 Radioligand Therapy in Patients with End-stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II Study
    Hao Fu, Jingxiong Huang, Liang Zhao, Yuhang Chen, Weizhi Xu, Jiayu Cai, Lingyu Yu, Yizhen Pang, Wei Guo, Bishan Su, Long Sun, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Haojun Chen
    Clinical Cancer Research 2025 31 8
  • Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy
    Yihui Luo, Haitian Fu, Chunjing Yu
    Frontiers in Pharmacology 2025 16
  • Comparing the diagnostic performance of DSC-MRI and FAPI PET in differentiating tumor progression from treatment-related changes in IDH-Wildtype Glioblastoma: A pilot study
    Hasan Önner, Halil Özer, Burak Gezer, Kazım Muslu Körez, Hakan Cebeci, Orhan Önder Eren, Ender Köktekir, Hakan Karabağlı
    European Journal of Radiology 2025 187
  • FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview
    Zhaoguo Lin, Pawel Rasinski, Ted Nilsson, Maria Holstensson, Yangmeihui Song, August Blomgren, Warissara Jutidamrongphan, Kalyani Pandya, Jimin Hong, Axel Rominger, Kuangyu Shi, Rimma Axelsson, Xiaoli Lan, Robert Seifert
    Seminars in Nuclear Medicine 2025
  • Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
    Anita Florit, Elizabeth J. de Koster, Serena Sassano, Lejla Alic, Giusi Pisano, Floris H. P. van Velden, Salvatore Annunziata, Irina Primac, Maria Rosaria Ruggiero, Cristina Müller, Evis Sala, Wolfgang P. Fendler, Giovanni Scambia, Lioe-Fee de Geus-Oei, Anna Fagotti, Vittoria Rufini, Angela Collarino
    European Journal of Nuclear Medicine and Molecular Imaging 2025

Article usage

Article usage: November 2024 to April 2025

AbstractFullPdf
Nov 20240629721
Dec 202401115816
Jan 202502102820
Feb 202501056480
Mar 20250648261
Apr 20250802320
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (1)
Journal of Nuclear Medicine
Vol. 66, Issue 1
January 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
Thomas A. Hope, Jeremie Calais, Ajit H. Goenka, Uwe Haberkorn, Mark Konijnenberg, Jonathan McConathy, Daniela E. Oprea-Lager, Laura Trimnal, Elcin Zan, Ken Herrmann, Christophe M. Deroose
Journal of Nuclear Medicine Jan 2025, 66 (1) 26-33; DOI: 10.2967/jnumed.124.269002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
Thomas A. Hope, Jeremie Calais, Ajit H. Goenka, Uwe Haberkorn, Mark Konijnenberg, Jonathan McConathy, Daniela E. Oprea-Lager, Laura Trimnal, Elcin Zan, Ken Herrmann, Christophe M. Deroose
Journal of Nuclear Medicine Jan 2025, 66 (1) 26-33; DOI: 10.2967/jnumed.124.269002
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • 1. PREAMBLE
    • 2. INTRODUCTION
    • 3. GOALS
    • 4. POTENTIAL CLINICAL INDICATIONS
    • 5. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL
    • 6. PROCEDURE/SPECIFICATIONS OF THE EXAMINATION
    • 7. DOCUMENTATION AND REPORTING
    • 8. DOSIMETRY
    • 9. WHAT DOES THE FIELD NEED
    • LIABILITY STATEMENT
    • ACKNOWLEDGEMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy
Show more PRACTICE STANDARDS

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire